Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study

被引：0
|
作者：
Artac, M. [1 ]
Korkmaz, L. [2 ]
Coskun, H. [3 ]
Dane, F. [4 ]
Karabulut, B. [5 ]
Karaagac, M. [2 ]
Cabuk, D. [6 ]
Karabulut, S. [7 ]
Aykan, F. [7 ]
Doruk, H. [8 ]
Avci, N. [9 ]
Turhal, S. [10 ]
机构：
[1] Necmettin Erbakan Univ, Meram Med Fac, Med Oncol, Konya, Turkey
[2] Necmettin Erbakan Univ, Med Oncol, Konya, Turkey
[3] Akdeniz Univ Med Oncol, Med Oncol, Antalya, Turkey
[4] Marmara Univ Hosp, Med Oncol, Istanbul, Turkey
[5] Ege Univ, Sch Med, Tulay Aktas Oncol, Izmir, Turkey
[6] Kocaeli Univ, Med Oncol, Kocaeli, Turkey
[7] Istanbul Univ, Inst Oncol, Med Oncol, Istanbul, Turkey
[8] Acibadem Bursa Hosp, Med Oncol, Bursa, Turkey
[9] Ali Osman Sonmez Oncol Hosp, Med Oncol & Hematol Clin, Med Oncol, Bursa, Turkey
[10] Anadolu Hlth Ctr, Med Oncol, Istanbul, Turkey
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw370.82
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
534P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study
    Artaç M.
    Coşkun H.Ş.
    Dane F.
    Karabulut B.
    Korkmaz L.
    Karaağaç M.
    Çabuk D.
    Karabulut S.
    Faruk Aykan N.
    Doruk H.
    Avcı N.
    Turhal N.S.
    Journal of Gastrointestinal Cancer, 2016, 47 (3) : 264 - 272
  • [2] Assessment of tumor-infiltrating lymphocytes in metastatic colorectal cancer patients treated by Bevacizumab-based chemotherapy
    Spano, J. P.
    Gobert, A.
    Mateescu, C.
    Mouawad, R.
    Bardier, A.
    Bachet, J. B.
    Dubreuilh, O.
    Varinot, J.
    Mitri, R.
    Khayat, D.
    Malouf, G.
    Capron, F.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S347 - S348
  • [3] VEGF and eNOS gene polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in patients with metastatic colorectal cancer
    Ulivi, P.
    Passardi, A.
    Marisi, G.
    Casacci, F.
    Scarpi, E.
    Valgiusti, M.
    Calistri, D.
    Del Re, M.
    Frassineti, G. L.
    Amadori, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S563 - S563
  • [4] Predictive value of VEGF gene polymorphisms in metastatic colorectal cancer patients treated with a bevacizumab-based chemotherapy.
    Ulivi, Paola
    Marisi, Giorgia
    Scarpi, Emanuela
    Passardi, Alessandro
    Ragazzini, Angela
    Frassineti, Giovanni Luca
    Zoli, Wainer
    Valgiusti, Martina
    Nanni, Oriana
    Calistri, Daniele
    Casacci, Fabio
    Amadori, Dino
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
    Xu, Ran
    Xu, Chen
    Liu, Chuntong
    Cui, Can
    Zhu, Jing
    ONCOTARGETS AND THERAPY, 2018, 11 : 8605 - 8621
  • [6] BEVACIZUMAB plus CHEMOTHERAPY BEYOND FIRST PROGRESSION IN METASTATIC COLORECTAL CANCER PATIENTS PREVIOUSLY TREATED WITH BEVACIZUMAB-BASED THERAPY: TML STUDY SUBGROUP FINDINGS
    Andre, Thierry
    Jose Maria, Vieitez
    Bouche, Olivier
    Bennouna, Jaafar
    Sastre, Javier
    Alonso-Orduna, Vicente
    Arnold, Dirk
    Osterlund, Pia
    Greil, Richard
    Van Cutsem, Eric
    von Moos, Roger
    Reyes-Rivera, Irmarie
    Makrutzki, Martina
    Kubicka, Stefan
    ANNALS OF ONCOLOGY, 2012, 23 : 14 - 14
  • [7] Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy
    Matsusaka, Satoshi
    Hanna, Diana L.
    Cao, Shu
    Zhang, Wu
    Yang, Dongyun
    Ning, Yan
    Sunakawa, Yu
    Okazaki, Satoshi
    Berger, Martin D.
    Miyamato, Yuji
    Parekh, Anish
    Stintzing, Sebastian
    Loupakis, Fotios
    Lenz, Heinz-Josef
    CLINICAL CANCER RESEARCH, 2016, 22 (13) : 3218 - 3226
  • [8] A Genetic Variant in CD274 Is Associated With Prognosis in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Based Chemotherapy
    Qin, Wan
    Zhao, Ben
    Wang, Duanrui
    Liu, Jiamin
    Zhou, Yilu
    Zhu, Wenjun
    Huang, Yongbiao
    Qiu, Hong
    Yuan, Xianglin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy
    Tokunaga, Ryuma
    Cao, Shu
    Naseem, Madiha
    Lo, Jae Ho
    Battaglin, Francesca
    Puccini, Alberto
    Berger, Martin D.
    Soni, Shivani
    Millstein, Joshua
    Zhang, Wu
    Stintzing, Sebastian
    Loupakis, Fotios
    Cremolini, Chiara
    Heinemann, Volker
    Falcone, Alfredo
    Lenz, Heinz-Josef
    CLINICAL COLORECTAL CANCER, 2019, 18 (01) : E8 - E19
  • [10] Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer
    Satoshi Matsusaka
    Mitsukuni Suenaga
    Yuji Mishima
    Koichi Takagi
    Yasuhito Terui
    Nobuyuki Mizunuma
    Kiyohiko Hatake
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 763 - 768
12345